A year ago, SwedenBIO initiated a series of activities to influence and support the training of the next generation talents, to lower the thresholds between academia and industry. Maja Neiman shares an update on how it is going.
Whether we are discussing prevention or treatment, with precision as the common thread, new ways of working, new knowledge, and the courage to try and evaluate new approaches are essential. No single discipline or profession can solve these challenges in isolation – interdisciplinarity and collaboration are required.
How interested are foreign companies in establishing themselves in the Stockholm-Uppsala region? How can we become even stronger? Ylva Hultman from Stockholm Business Region meets many international representatives and answers these questions here.
A key objective in Sweden's national life science strategy is to increase the number of high-quality clinical trials. Clinical trials are not only important for generating new knowledge about the safety and efficacy of pharmaceuticals – they also enable the healthcare system to implement new treatments more quickly and provide patients with early access to innovative therapies.
TEFs (European Testing and Experimentation Facilities) are large-scale testing environments where European technology providers can trial their AI-based software and hardware technologies in both physical and virtual settings. TEF-Health aims to both accelerate the introduction of AI and robotics in healthcare and promote collaboration.
SciLifeLab, Sweden's national center for molecular biosciences, supports the life science industry by providing access to its advanced research infrastructure. Each year, over 100 different companies, ranging from large corporations to small and medium-sized enterprises engage with SciLifeLab's infrastructure, fostering knowledge transfer between academia and industry.